Showing results (1751-1760 of 1,971) with videos related to
Sort By:
Pageof 198
International Journal of Cancer|June 15, 1989
Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriersT Kondo, H Kono, N Miyamoto, et al.Respiration Physiology|October 1, 1989
Direct write-out of particle size distribution of inhaled aerosol deposition using a laser scattering methodM Ishii, H Iijima, U Katsumata, et al.Digestion|January 25, 2014
Significance of background coloration in endoscopic detection of early esophageal squamous cell carcinomaH Minami, H Isomoto, H Inoue, et al.Journal of Viral Hepatitis|July 6, 2012
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeksM P Manns, H Wedemeyer, A Singer, et al.Cancer Investigation|January 1, 1994
Laboratory correlates of chemoimmunotherapy with low-dose recombinant interleukin-2 and mitomycin C in patients with advanced carcinomaS Arinaga, N Karimine, K Takamuku, et al.Endoscopy|February 1, 2003
Newly developed 3D endoscopic system: preliminary experienceT Yoshida, H Inoue, E Hara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1989
[Chemotherapy with Cisplatin-Phosphatidyl-choline-Lipiodol (CPL) suspension in unresectable hepatocellular carcinoma]Y Aoki, K Hirai, K Yamashita, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1992
[Clinical significance of alpha(1----3)-L-fucosyltransferase activities in sera from patients with malignant diseases with a special reference to a potential tumor marker]M Kimura, S Yazawa, T Koida, et al.British Journal of Cancer|May 25, 2006
Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatmentK Mimori, N Sadanaga, Y Yoshikawa, et al.Diabetes Research and Clinical Practice|November 27, 2004
Possible contribution of adipocytokines on diabetic neuropathyM Matsuda, F Kawasaki, H Inoue, et al.Pageof 198